Asia Pharma R&D Outsourcing Congress

Elevating Asia to a Global R&D Innovation Partner

Government, Academic and Industry Investment a High Priority

Regulatory Harmonisation: Increasing Cooperation between Governmental Agencies

Evaluating the Risk-Opportunity before Selecting a Regional Outsourcing Partner

Examining Whether Intellectual Property Protection (IPP) Poses a Threat to Outsourced Activity 

The Changing Face of Asian Pharma R&D – Moving from Global to Local Healthcare Needs

An Assessment of Homegrown Drug Discovery Capabilities from Lead Identification through to Preclinical Studies

Collaborating With Academia as Outsourcing Partners Provides Access to New Technologies and Scientific Expertise

Conducting Integrated Drug Discovery Programs Utilising CROs in India and China

Case Study: A Firsthand Account of Outsourcing Drug Discovery Research to Asia 

Dr. James Garner, Vice President and Managing Director, Takeda Clinical Research, Singapore (Confirmed)

Dr. Steve Yang, Vice President R&D Asia, Pfizer (Invited)

Dr Pascal Touchon, Director Head of Scientific Collaborations and Business Development, Sevier Laboratories (Invited)

Dr Harron Hashmi, Director Drug Development Asia-Pacific, Biogen-Idec (Confirmed) 

Dr Jianzhong Shen, Asia Regional IP Counsel, Eli Lilly China (Confirmed) 

Dr Marc Cluzel, Executive Vice President R&D, Sanofi Aventis (Invited) 

Dr Jingsong Wang, Director Discovery Medicine / Clinical Pharmacology, Bristol-Myers Squibb 

Dr Frederik Deroose, Director Head of External Collaborations and Outsourcing Services, Johnson and Johnson (Confirmed)

Dr John Mathew, Head External Discovery and Preclinical Sciences Operations, Merck & Co (Confirmed) 

Dr Sham Nikam, Vice President Head Global Discovery, Nycomed (Confirmed)

Registration is currently open. Please contact the Conference Director -Steve Hambrook

Tel : +44 (0) 1865 811 189

Email: steve@globalengage.co.uk